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Case 1 * 
A 41-year-old 70-kg woman presentcd with a history of 
headache, palpitations, and hypertension. The diagnosis of 
pheochromocytoma had been made 18 years previously on 
the basis of elevatcd plasma and urinaty catecholamines. At 
that time, an exploratory laparotomy resulted in the exci- 
sion of the left adrenal gland, which showcd no pheochro- 
mocytoma. Her symptoms and blood pressure were wel1 
controlled following surgcry, using alpha-methyl-p-tyrosinc 
(AMPT) and propranolol. and no further investigations 
were performed. Further symptoms 6 months prior to this 
admission prompted investigation using metaiodobenzylgua- 
nidine (MIBG) stans in an attempt to localize the tumor. 
Two initial is11 MIBG stans were negative but a iz31 MIBG 
scan suggcsted an abnormal focus in the right adrenal 
gland. AMPT was discontinued and phenoxybcnzamine 
added to her treatment regimen before surgery. An unevent- 
ful laparotomy was pcrformed to remove the remaining 
adrenal gland but again histology proved negative. Further 
laboratoty investigations stil1 demonstrated elevated plasma 
and urinary catecholamines (Table 1). Positron emission 
tomography and rapid-sequencc contrast-enhanccd comput- 
erized axial tomography (dynamic computcd tomography 
[Cr] scanning) demonstrated a 6 cm diameter mass in the 
region of thc left atrium. Thc patient was scheduled for 
thoracotomy. Routine hematology, biochemistry, chest rddio- 
graphy, and a 12-lead electrocardiogram were normal. A 
surfacc echocardiogram was normal but a preoperative 
transesophageal echocardiogram confirmed thc prcscncc of 
thc lcft atrial mass and dcmonstrated normal left ventricu- 
lar function. 
Antihypertensive medication 48 hours prior to surgcry 
was as fellows: phenoxybenzamine. 40 mg orally four timcs 
a day; propranolol, 20 mg orally four times a day; and 
nifedipine slow release, 10 mg orally twice a day. Thc hcart 
rate (HR) was 80 to 90 beats/min and blood prcssure (BP) 
140/90 to 160/ 100 mmHg supinc, 90/50 mmHg on standing 
(arm culfand auscultation of the brachial artery). Thc usual 
doses of antihypertensivc mcdication wcrc given on the 
morning of surgery. Oral lorazepam. 2 mg, and intramuscu- 
lar morphinc, 8 mg, scopolaminc, 0.2 mg, and hydrocorti- 
sone, 100 mg, wcrc given as prcmedication. Before induc- 
tion of ancsthcsia. two 14g pcriphcral intravenous catheters. 
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a 20g right radial arterial catheter, and a balloon-tipped, 
flow-directed, pulmonary artety catheter (via the right 
internal jugular vein) were inserted. A triple-lumen cath- 
eter was also inierted in the right internal jugular vein for 
intraveneus vasoactive drug infusions. The patient re- 
mained adequately sedated bcfore induction and hemody- 
namically stable on arrival in the preoperative holding area. 
Howevcr, after inscrtion of thc arterial line the HR rose to 
110 beats/min. Sinus rhythm and the invasive arterial BP 
were measured at 190/115 mmHg. Labetolol, 7.5 mg 
intravenously (IV), in divided doses of 2.5 mg, reduced the 
HR to 80 beats/min and BP to 170/100 mmHg. 
Immediately before induction, the HR was 110 heats/ 
min and BP 190/110 mmHg; esmolol (200 pgikglmin 
rcducing to 20 Fg/kg/min after 5 minutcs) and sodium 
nitroprussidc (1.0 ug/kg/min) reduced the HR to 80 
bcats/min and BP to 150/70 mmHg. Anesthesia was in- 
duced using fentanyl (1 mg). 50% nitrous oxide in oxygen, 
thiamylal, 200 mg, followed by 2% isofluranc. Muscle 
relaxation was achieved using vecuronium (10 mg) and the 
patient’s trachea was intubated without difficulty. Anesthc- 
sis was maintained using 50% nitrous oxidc in oxygen, 1% 
isollurane, and incremental fcntanyl (total 2 mg); mus& 
relaxation was maintained using a vecuronium infusion (6 
to 8 mgihr). The arterial carbon dioxide tension was 
maintained bctwecn 30 to 40 mmHg. The HR remained 60 
to 90 beats/min and BP 120160 to 150/100 mmHg during 
intubation, skin incision, sternotomy, and aortic cannula- 
tion: thc pulmonary artery pressurc remained less than 
35! 12 mmHg during the pre-cardiopulmonary bypass (CPB) 
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Table 1. Plasma Catecholamine Levels Before Thoracic 
Surgery (Case 1) 
~ _- _ .._ 
Plasma Level Normal Range 
Catecholamine bg;mL) Il~g~mLI 
- 
Norepinephrine 5,793 0-500 
Epinephrine 121 0-100 
Dopamine 3,918 0-100 
.~ 
period. Control of HR was achicved using esmolol(10 to 20 
kgikgimin) throughout thc pre-CPB period, and BP using 
2% isoflurane and nitroprussidc (0-0.3 ugikgimin). Therc 
was one episode of transient hypotension (60 mmHg 
systolic) during insertion of thc venous bypass cannula and 
one episode of transicnt hypertension (200 mmHg systolic 
for 1 minutc) during manipulation of the tumor mass hefore 
CPB. During CPB at 28”C, pump flows of 2 to 2.4 L!min!m’ 
were maintained with a hematocrit of greatcr than IS%. 
Mean systemic BP was maintained between 40 and 70 
mmHg using smal1 incremcnts of phcnylcphrine (50 to 100 
pg). 
A sessilc tumor, approximatcly 5 cm in diameter. was 
found within thc left atrium and attachcd to the posterior 
wall. Thc tumor mass encroachcd upon all four oritices of 
the pulmonary veins. The distal aortic arch was temporarily 
divided to obtain surgical access. The tumor and adjacent 
Icft atrium, incfuding thc distal pulmonary veins, wcrc 
exciscd complctcly. Thc atrial defect was repaircd using a 
large patch of pericardium and the four pulmonary veins 
were anastomosed to the patch. Total timc spent on CPB 
was 322 minutes. 
Hypotension during weaning from CPB (BP 65/.X mmHg) 
was due to a mild reduction in cardiac output (CO) (3.X 
L/min), measurcd by thcrmodilution, and low calculated 
systcmic vascular resistance (SVR) of 735 dynes sec. cm-‘. 
This was treatcd with volume infusion and dobutamine (5 
uglkgimin) to restore CO to greatcr than 4.5 L/min. 
Norepinephrinc (0.1 to 0.2 ug/kg/min) was added to 
maintain BP at greater than 100 mmHg systolic (Tablc 2). 
Intraopcrative transesophageal echocardiography (Sonos 
1000. Hewlett Packard, Palo Alto, CA) assisted in the 
estimation of Ieft ventricular filling volume and contractility 
by comparing views of the prc-CPB and post-CPB periods. 
Lcft ventricular ejection fraction was formally calculatcd 
only during thc pre-CPB period (approximately 55%): 
post-CPB images of the left ventricle were thcn compared 
directly with the pre-CPB image as an assessmcnt of filling 
and contractility. During weaning, qualitative echocardio- 
graphic assessment rcvealed decrcased left ventricular 
filling and thc requiremcnt for volume administration. 
Comparativc values for BP, CO, and SVR during the 
preinduction, pre-CPB, and post-CPB periods are given in 
Table 2. 
At thc end of surgery the patient was transferred to thc 
cardiothoracic intensive care unit, intubated, and venti- 
lated. She remained hemodynamically stable but returned 
to the opcrating room after 4 hours because of cxcessivc 
bleeding from the chest drains; a smal1 arterial bleeding 
point in the left atrium was found and secured. Weaning off 
dobutamine and norepinephrine was accomplished on the 
\ccond postopcrarivc day and thc paticnt was cxtubarcd on 
thc third postopcrativc day. Small doses of oral captopril 
and propranolol wcrc rcquircd in thc lirst 10 days following 
cxtubation to control bloed prcssure and heart ratc. 
Thc paticnt wds maintaincd on hydrocortisonc. lfHt mg 
every 6 hours. throughout thc pcrioperative pcriod com- 
mcncing with thc prcmedication: a furthcr 100 mg uas 
givcn intraopcralivcly jus1 prior to thc tcrmination of CPB. 
In thc postopcrativc pcriod thc dosc of hydrocortisonc was 
reduced and wcaned following extubation. Thc patient was 
finally dischargcd from thc hospita1 3 weeks aftcr surgery on 
stcroid rcplaccmcnt thcrapy and no antihypcrtcnsivc thcrapy 
(BP 13O:YO mmHg supinc). Histologie analysi\ of thc 
surgical spccimcn confrmcd thc diagnosis of phcochromo- 
cytoma. 
(‘UC, 2i 
The patient was a 27-year-old, 75kg. Egyptian woman 
with a ó-month history of hypcrtcnsion and diaphoresis. 
After an cxtcnsivc work-up shc was found to have an 
unrcsectablc, intracardiac phcochromocytoma that was 
isolatcd to structurcs of thc teft hcart. Shc was transfcrrcd 
to this institution for considcration for orthotopic heart 
transplantation. Thc paticnt had no symptoms of dyspnea. 
chcst pain. pulmonary cdcma, or heart failurc. Therc was 
no history of drug allcrgies. Her current medications 
included propranolol and dibcnzyline. Her medical history 
was othcrwise noncontributory. She was deemed an acccpt- 
ablc transplant candidate. 
A suitablc donor heart was eventually procurcd. The 
paticnt was brought to thc operating room, anxious. but 
without any specific complaints. Shc had eatcn a solid mcal 
2 hours prior to arrival in the opcrating room. Her heart 
ratc was 98 beats/min, BP 148195 mmHg, 100% OZ satura- 
tion by pulse oximctry, and sinus rhythm without conduc- 
tion defect on the electrocardiogram. Two large-bore periph- 
eral intravenous catheters and an intra-arterial monitoring 
catheter were insertcd. The patient was administercd 
oxygcn, 5 L/min via nasat cannula, and midazolam. 2 mg. 
was administcrcd intravenously. A pulmonary artery cath- 
eter was thcn insertcd and rcvcaled thc following: PAP 
28!Y mmHg. ccntral venous pressure (CVP) 5 mmHg. and 
cardiac output 6.8 Limin. During the insertion of thc 
catheter, thc patient was given propranolol, 3 mg IV in 
divided doses. in order 10 control her HR betwecn 95 and 
105 beats!min and an additional dose of midazolam, 3 mg 
IV, to allay her anxiety. After preoxygenation with 100% 0; 
for 5 minutes, rapid-scquence induction, and intubation of 
thc trachea using cricoid pressure wcrc easily accomptished 
with sodium thiopental, 500 mg, fentanyl, 2 mg, tidocaine. 
100 mg, and vecuronium, 14 mg. Intravenous lidocaine was 
used to attenuate a possible increased hemodynamic re- 
sponse to laryngoscopy and intubation. At this time, the BP 
rose to lY6iYO mmHg and the HR remained stable between 
YO and 100 beats/min. Following trachea1 intubation, a 
5-MHz biplanc transesophageal echocardiography (TEE) 
S.L. Mullis. MD. and S. 1 lemma. MD 
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Table 2. Case 1: Comparison of Rapresentative Hemodynamk Parameters and Trestment at Four Different Timw 
During the Perioporathre Perkd 
Preinduction Pre-CPB Weaning CPB Post-CPB 
Heart rate 
(beatslmin) 110 80 90 90 
Bloed pressure (mmHg) 190/110 140190 65135 105/55 
CVP (mmlig) 7 9 10 10 
PAP (mmlig) 2216 24112 30/14 28115 
Cardiac output (L/min) 6.0 5.8 3.8 5.0 
Cardiac index (L/minlm2) 3.2 3.2 2.1 2.7 
SVR* (dynes.secxm-5) 1730 1340 735 990 
Treatment Labetolol Anesthesia Volume Dobutamine 
Nitroprusside Nitroprusside Dobutamine Norepinephrine 
Esmolol Esmolol Norepinephrine 
Abbreviations: CVP, central venous pressure: PAP, pulmonary artery pressure; SVR, systemic vascular resistance. 
??SVR = 80 (mean systemic blood pressure - central venous pressure/cardiac output). Normal range: 900 to 1,500 (dynes.sec.cm.5j.s 
probc was inserted into the esophagus and attachcd to a 
Hcwlett-Packard Sonos 100 machine. A mass measuring 
approximately 8 cm by 5 cm was seen antcrolateral to the 
aortic root and left ventriclc. This mass compresscd the left 
atrium and cxtended to the mid-left vcntricular Icvel. It 
appcared to bc wel1 delineated without extension into thc 
cardiac chambers. The short-axis view revcaled no evidcnce 
of Icft ventricular hypertrophy or dyskinesis. None of thc 
valves was involved (Fig 1). 
Genera1 ancsthcsia was maintained with oxygen, fen- 
tanyl, isoflurane, and vecuronium. In addition to decpcning 
anesthesia, nitroprussidc was used to treat intcrmittent 
systolic blood pressurc elevations of 150 to 180 mmHg. 
During these acute hypertensivc episodes, thc TEE re- 
vealed a hypcrdynamic left ventricle without evidencc of 
wall motion abnormalities. Arterial blood gas detcrmina- 
tions were monitored serially and urinary output was 
mcasured at 30-minute intervals. A median stcrnotomy was 
pcrformed and the operativc course was unremarkablc 
prior to CPB and aortic cross-clamping. The tumor was 
poorly cncapsulated and demonstrated such extensive inva- 
sion of the walls of thc left atrium and ventricle that 
complete removal could not be achieved with full thickncss 
excision and pericardial patch grafting. The paticnt undcr- 
went cardiac allotransplantation and was wcaned from 
cardiopulmonary bypass on isoproterenol(O.1 mgimin) and 
dopamine (3 pg/kg/min), requiring only a brief period of 
norcpinephrine (0.05 kg/kg/min) administration immedi- 
ately following CPB to maintain systolic BP greater than 
100 mmHg. Cardiac output determinations following CPB 
ranged from 6.9 to 8.8 L/min. She was transfcrred to thc 
ICU in stable condition and was extubatcd uncventfully on 
the second postopcrative day. There was no rccurrcncc of 
her hypertension and her only medications upon discharge 
were acyclovir, cyclosporinc, and vitamins. 
DISCUSSIONS 
Pheochromocytomas are rare catccholaminc-sccreting 
tumors found in approximately 0.1% of all hypertensive 
patients.’ Approximately 18% of all phcochromocytomas 
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are extra-adrenal,l with 75% of extra-adrenal tumors lo- 
catcd between the diaphragm and the aortic bifurcation. 
Less than 2% of all pheochromocytomas are intrathoracic; 
middlc mediastinal tumors of the heart and pericardium 
are even rarer with the tumor mass usually relatcd to the 
left atrial wall.” Although the diagnosis and surgical manage- 
ment of thoracic pheochromocytomas rcquiring CPB have 
been describcd previously,3-h a description of the anesthetic 
technique did not appear in the literature. 
Localization of intrathoracic pheochromocytomas may 
bc difficult, rcsulting in multiple investigations and negative 
laparotomy.4 In a review of the surgical literature, Jebara et 
al0 found only 30 rcported cases of intracardiac pheochro- 
mocytomas during an 18-year period. Most cases had been 
rcported in the past 6 years, suggesting an improvement in 
thc diagnostic techniques availablc. 
Rapid-sequencc intravenous contrast computerized axial 
tomographic scanning (dynamic CT scanning) and IJ11 
MIBG scanning (with blood-pool and skeletal imaging) 
have been dcscribed as effectivc techniques in the localiza- 
tion of these tumors4 Scintigraphy using 13’1 MIBG may bc 
particularly helpful in patients with recurrent discase if 
used in association with other techniques such as magnetic 
rcsonance imaging and computerized axial tomography. 
Maurca ct al’compared these threc techniques, reporting a 
sensitivity of 83% and a specificity of 100% for IJ’1 MIBG 
scanning in patients with extra-adrenal or malignant tu- 
mors. It has been suggested that lZ31 MIBG may be superior 
to “‘1 MIBG scanning in paticnts with neural crest tumors.K 
Case 1 was unusual in that Ij11 MIBG and lLzI MIBG 
scanning wcrc both misleading, suggesting a tumor in thc 
remaining adrcnal gland. This tumor was finally localizcd to 
the lcft atrium using dynamic CT scanning and l’C-labclcd 
hydroxyephedrine positron emission tomography. The lat- 
ter tcchnique has been described by Shulkin et al.” Thc 
imaging techniques used for the localization of pheochromo- 
cytomas have been recently revicwed by Chatal.: 
Inhalation, intravcnous, and rcgional anesthetic tech- 
niques have all been used successfully in the management 
of patients with phcochromocytomas.“’ Thc importante of 
adequate prcopcrative hcmodynamic control (bloed pres- 
WK. arrhythmias. bloed volume) hefore >urgery has been 
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Fig 1. Case 2. (A) A modifiid five-chamber view of 
the hoort using the horizontal probe. lhis demon- 
strotes the mars anterolateral to the aortk root. 
Abbrevlations: AV, rortk valve; LA, Ieft atrium; RA, 
right atrium; RV, right ventrkle. (B) A two-chamber 
view using the vertiwl plane. lhis demonstrates the 
mau in the pericardium anterior to the LV. Abbrevia- 
tion: MV, mitral valve. 
dcscribed by a numbcr of authors.‘.” r3 Alpha-mcthyl-p- 
tyrosinc inhibits tyrosinc hydroxylasc and blocks thc ratc- 
limitingconversion of tyrosinc to dopa in the catccholaminc 
synthesis pathway.’ AMPT may bc particularly uscful in 
patients with malignant phcochromocytomas. or in thosc 
for whom surgery is contraindicatcd.14 Howcvcr. a tumor 
partially supprcsscd by AMPT may stil1 causc major prcssor 
responses during surgcry; thc addition of an u-adrcnorccep- 
tor antagonist is cssential and phenoxybenzaminc remains 
thc drug of choice.’ Satisfactory preopcrative hcmodynamic 
control was achicved in Case 1 using oral phcnoxybcnza- 
minc, propranolol and nifedipine; these drugs were givcn 
up to and including the morning of surgery. Thc combina- 
tion of lorazepam, morphinc, and scopolaminc has been 
rccommcnded as premcdication for paticnts with phcochro- 
mocytoma,“ although othcr authors have suggested that 
morphine should be avoidcd because of histamine-induccd 
catccholaminc rclease.‘.lZ Atropinc premedication, if it is 
given at all, should bc given with caution to pcdiatric 
pheochromocytoma patients because of its chronotropic 
cffccts.‘? Although patient 1 was adcquatcly sedated and 
initially hcmodynamically stable after prcmcdication, the 
fìrst direct artcrial BP reading before induction of ancsthc- 
sis was IWi I IS mmHg. 
ft was anticipatcd that largc doses of anesthetic agcnts, 
nitroprussidc. and a f%adrenoreceptor antagonist might bc 
rcquircd to control fluctuations in HR and BP in the period 
bcforc CPB, especially during exploration of thc mediasti- 
num and manipulation of the heart. Nicholas et alrh used a 
propranolol bolus (3 mg IV) followed by esmolol (up to 300 
kg:kg!min) and sodium nitroprussidc for hemodynamic 
control during laparotomy for pheochromocytoma resec- 
tion. Gabriclson et al’: used esmolol (up to 250 uglkgimin 
without an initial bolus) and phentolamine without cardio- 
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pulmonary bypass. Isoflurane and sodium nitroprusside 
were used as the primary agents to control hypertcnsion; 
esmolol was thcn titrated to maintain a heart rate of less 
than 80 beats/min. There is some cvidence that the elimina- 
tion of esmolol is slightly prolonged in anesthetized patients 
receiving chronic @blocking agents; this effect is unlikely to 
be clinically important and the dosage of esmolol can be 
titrated to individual effect.ix In Case 1, esmolol was 
maintained at the relatively low infusion rate of 10 to 20 
ug/kg/min, following the initial infusion of 200 ug/ kg/min 
during induction of anesthesia. 
Boluses of labetolol(7.5 mg in total) were used to control 
hoth tachycardia and hypertension immediately beforc 
induction of anesthesia. Thc greater duration of action of 
labetolol, compared to esmolol, was useful during the 
period while the patient was movcd from the preoperativc 
area to the operating room. It has been suggestcd that 
intravenous labetolol, which is predominantly a B-blocker, 
may give unreliable responses when used in patients with 
pheochromocytoma. i7 In the authors’ experience it may be 
used undcr these circumstances, primarily to control heart 
ratc and thus rcduce hypcrtension, in conjunction with 
preexisting alpha blockade (usually phenoxybenzamine). 
There are little data concerning thc pharmacodynamics 
of @adrenoreceptor antagonist drugs before. during, and 
after CPB. In human subjects, plasma propranolol levcls 
drop after thc onset of hypothermie CPB but rise again 
after the termination of CPB.“.?” A peak in plasma pro- 
pranolol levels occurs during rewarming on CPB in dogs.?’ 
Esmolol is an ultra-short-acting Bi-adrenorcceptor antago- 
nist with a rapid onset of action and rapid mctabolism to a 
metabolitc which is 1,500 times less potent than csmolol 
itself.?? In Case 1 esmolol was selected to minimizc the 
effects of residual beta-adrenergic blockade during weaning 
from CPB. Hypotension at this time was due to a low 
systcmic vascular resistance and depression of cardiac 
output due primarily to a reduction in preload. Hypotcn- 
sion has been reported previously following resection of 
pheochromocytoma and is thought to be due to residual 
alpha-adrcnergic blockadc and fall in plasma catechol- 
aminc levels after tumor resection.’ The simultaneous 
measurement of CO, systemic BP, and centra1 vcnous 
pressurc following CPB allowed SVR to bc calculated and 
kept within the normal range using norepinephrine. 
Cardiomyopathy has been rcported to bc present in 20% 
to 30% of patients with pheochromocytoma.Z2 In Case I, 
thcrc was no echocardiographic evidente of prcoperative 
lcft ventricular dysfunction. Low cardiac output syndromc 
following cardiopulmonary bypass may bc due to a number 
of factors including arrhythmias, decreased preload. vol- 
ume overload, increased afterload, and myocardial dysfunc- 
tion.L4 In Case 1 there was no echocardiographic evidente 
of ventricular dysfunction during the intraopcrativc period 
and the mild reduction in CO postbypass was secondaty to a 
decrease in preload demonstrated by serial qualitativc 
echocardiographic assessment. Thc simultaneous incrcasc 
in SVR, using norepinephrinc, may also have improvcd 
coronaty artcrial perfusion and ventricular function. 
Hemodynamic dysfunction related to the presence of an 
atrial mass was a further consideration. Atrial myxomas are 
the most common primary tumor of the heart. These 
tumors may cause atrial arrhythmias, obstruct left atrial 
outflow (in which case central venous and pulmonary 
capillary wedge pressure will no longer reflect left vcntricu- 
lar end-diastolic pressurc), embolize fragments of tumor or 
release vasoactive substances (particularly vasoactive intes- 
tinal polypeptide [VIP]).Zs A pulmonary artery catheter 
should be avoided in the presence of a right atrial mass. 
This potential list of problems may all have been encoun- 
tcrcd in the reported cases. In particular, tachycardia and 
tachyarrhythmias due to acidosis, electrolytc imbalance, 
and inotropic agents were avoided. 
Thc commonest serieus postoperative complication and 
cause of mortality in patients undergoing surgical resection 
of cardiac pheochromocytoma is massive bleeding. Jebara 
ct al” rcported 25 cases of paticnts undergoing surgical 
rescction of a cardiac pheochromocytoma: therc were 21 
survivors, 20 of whom were reported to be completely 
cured. All 4 deaths were due to massive bleeding shortly 
aftcr surgery. Case 1 rcturned to the operating room after 4 
hours following cxcessive bleeding from the chest drains. 
Finally. the rclationship between pulmonary capillary 
wedgc prcssurc and left atrial pressure or Icft ventricular 
end-diastolic volume may be poor following CPB.?” In Case 
1 it was anticipatcd that distortion of the left atrium and 
pulmonary veins. following surgical repair, might furthcr 
limit thc valuc of pulmonaty arterial monitoring to estimatc 
Icft vcntricular hlling. Measurement of direct left atrial 
pressurc in this case may have proved useful. In fact, during 
wcaning from CPB it was found that cchocardiographic 
changes in Icft ventricular function (filling and contractility) 
were paralleled by similar changes in pulmonary artery 
diastolic prcssurc, CO, and systemic BP. 
To summarizc, a number of important issues should be 
considered in the management of these rare cases: these 
include difficulty in preoperative tumor localization, ad- 
cquate preoperativc control of hemodynamic variables, 
intraoperative hemodynamic fluctuation dut to catechol- 
amines or the presencc of an atrial mass, a low SVR 
following tumor resection, and thc possibility of massive 
hlood loss in thc immediate postoperativc period. 
COMMENTARYZ 
The report of these two paticnts presenting with cardiac 
pheochromocytoma is noteworthy for multiple reasons. 
First. these cases illustrate many of the current and ad- 
vanced diagnostic techniques used for identifying pheochro- 
mocytomas. Second, various combinations of l3-adrenergic 
blockers and vasodilators were used effectively to control 
the hemodynamic derangements. Lastly, and perhaps most 
importantly, there is a presentation for thc first time in the 
anesthesia literature of a detailed description of the care of 
two patients with cardiac pheochromocytomas. 
BGeorgr V. Gahrielson. X4D 
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Thc fitst paticnt is a 41-ycar-old woman who undcrwcnt 
two unsuccessful adrenalectomies to resect a symptomatic 
pheochromocytoma. Ultimatcly. a left atrial tumor was 
diagnosed using PET scanning, dynamic C’T. and linally 
transcsophageal echocardiography. Surgical rcscction was 
planned using cardiopulmonary bypass. Thc second paticnt 
is a 27-ycar-old woman who was found to have an unrcscct- 
ablc intracardiac tumor aftcr an cxtensivc workup. Shc was 
scheduled for cardiac transplantation. also with CPB. Even 
without thc tumors secreting vasoactive amines. thcsc cases 
would present many complex ancsthetic problems. Supcrim- 
posed upon this. sccretion of these vasoactivc compounds 
evokcs thc real possibility of suddcn and profound hemody- 
namic changcs that must bc dealt with. Mcdications used to 
control hypertension may substantially incrcase thc ditb- 
culty in wcaning from CPB.” Thus. particular attcntion 
must be paid to their choicc. and short-acting agcnts are 
prcfcrred. 
The first patient was managcd intraoperativcly with 
labctalol and esmolol for beta-adrencrgic blockade and 
with sodium nitroprusside (SNP) added as a potent vasodi- 
lator, as is recommendcd for rapid and prccisc titration of 
blood prcssure.:k Esmolol alom may have sufhccd herc for 
beta-blockadci7: howcver, thc combination of a longer 
acting agent with a very short duration onc may have somc 
merit in “smoothing out thc course.” The sccond case was 
managcd intraoperativcly with smal1 doses of propranolol 
in combination with SNP again for rapid and prccisc 
control of BP and hcart rate. She had received prior 
alpha-adrenergic blockade with the long-acting blockcr. 
dibcnzyline. which. along with intravascular volume cxpan- 
sion, remains the mainstay of therapy hcrc.z”,“l 
It is unfortunate that only from numerous case rcports 
can a bcttcr picture of this discasc hc obtaincd. Numerous 
anccdotal rcports (too numerous to mention) have con- 
firmed the safcty or dangcr of various drugs uscd in this 
condition. Thc current mortality from surgical rescction of 
this tumor intraabdominally is quite low.” What rcmains 
are problems with special situations such as phcochromocy- 
toma that arc previously undiagnoscd,“ occur in prcg- 
nancy, ‘; or are locatcd in extra-adrcnal sitcs such as thc 
heart.’ With this report thcrc is now thc beginning of a 
picture of problcms associated with management of cardiac 
pheochromocytoma. 
These cases remind me of a similar onc that 1 cared for 
not too long ago. A middle-aged man who had previously 
undcrgonc cardiac transplantation now prcsented for a 
rescction of an intraabdominal phcochromocytoma. Thc 
actions of various ancsthetic and vasoactive mcdications 
uscd in the trcatment of pheochromocytoma had to be 
scrutinizcd for usc in the denctvatcd heart. This was more 
than a novelty case or a worst-case scenario board- 
examination question. It represented a challenging pharma- 
cologic cxcrcise for even thc most expcricnccd anesthcsiolo- 
gist. and one 1 wil1 long rcmember. The cases prcsenled 
hcrc are likcwise superb cxamplcs of challenging clinical 
and academie cxcrcises for all to share. 
COMMENTARYI 
Extra-adrcnal phcochromoCytomas arc rare. Thcy ;rrc 
usually locatcd in thc abdomen. Thora& pheochromocyto- 
nias constitutc Icí 10 Y’ c of all cases of phcochromocyto- 
mas and arc usually found in thc postcrior mcdiastinum. 
C‘ardiac phcochromocytomas are cxtremcly rare, with fcwcr 
than 50 cases rcported in thc litcraturc.” Diagnosis and 
managcmcnt of thcsc tumors constitutc a challcnging 
problcm to both thc medical and thc surgical team. 
Diagnosis of cardiac phcochromocytomas is consistently 
difhcult to cstablish. In most instanccs. multiple invcstiga- 
tivc procedures arc pcrformcd in different combinations 
over sevcral ycars hcfore thc sitc of thc Icsion is localizcd. 
Purthermorc, during the diagnostic workup, ncgativc explor- 
story laparotomy was performed in over half of thc GISCS,‘~ 
two of whom died postopcrativcly.‘J~15 Thc most uscful 
study to establish thc diagnosis of cardiac phcochromocyto- 
mas is iodinc 13 I -labclcd metaiodobenzyl guanidinc (I- 
MIBG) scintigraphy.’ This tcchniquc rcsultcd in localiza- 
tion of thc tumor in IX of thc 72 paticnts in whom it was 
uscd. 
Two-dimcnsional cchocardiography is particularly hclp- 
ful when thc tumor has an intracardiac cxtension. Thc CT 
scan had a vcry low diagnostic yicld becausc it tias pcr- 
formcd in most cases and revcalcd thc diagnosis in only onc 
paticnt. However. after thc diagnosis had been cstahlishcd 
using anothcr tcchnique, retrospectivc analysis of thc CT 
scan showcd thc exact location of thc tumor. Rccently, 
rapid-scquencc contrast-enhanccd CT scan (dynamic CT) 
proved to bc promising in thc diagnosis of cardiac pheochro- 
mocytomas. Magnctic rcsonancc imaging (MRI), with its 
superior soft-tissuc contrast. appcars to hc a modality with 
grcat diagnostic potcntial. Howcvcr. as with dynumic CT, 
cxpcricncc with thcsc two techniqucs is vcry limited. 
Morcovcr. in thc rare cases whcrc it was obtaincd. MRI did 
not help cstablish thc diagnosis. As with thc C’T scan, 
rctrospectivc analysis of thc MRI images aftcr thc diagnosis 
had been mads allowcd visualization of thc tumor. 
Pheochromocytomas arc most often found on thc roof of 
thc Icft atrium. Other locations includc thc intcratrial 
septum and thc antcrior surface of thc hcart bctwccn thc 
aortic root and the pulmonary artcry with possiblc postcrior 
cxtcnsion. Coronary angiography is a valuable proccdurc 
bccausc it shows thc exact location of thc tumor as wcll as 
its relation to thc coronary vcsscls. It also indicatcs thc 
origin of thc bloed supply of thc pheochromocytoma and 
hclps in thc planning of the surgical proccdurc. 
Surgical cxcision of thcsc tumors offers permanent curc. 
t lowcvcr. carcful ancsthetic prcparation is mandatory be- 
fort the operation. An important characteristic fcaturc of 
rcscction of cardiac phcochromocytomas is thc usc of 
cardiopulmonary bypass. This allows total cxclusion of thc 
hcart aftcr cardioplegic arrest with the aorta cross-clampcd 
and both vsna cavac snarcd. Unlikc othcr cxtracardiac 
locations. thc tumor can then hc cxcised without risk of 
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hypertension or arrhythmias and with minima] bloed IOSS. 
Furthermorc, aortic cross-clamping allows safe dissection 
of the mass from the underlying myocardium and from the 
coronary vessels. It also allows the performance of coronary 
artery procedures to completely excisc the mass. In some 
cases a segment of the lcft atrial wal] containing the tumor 
is resected and rcplaced by a pericardial or Dacron patch. 
Some authors advocate transection of the great vessels to 
obtain access to pheochromocytomas of the roof of the left 
atrium.3h Cooley et aV7 in 1985 described a new surgical 
approach to treat extensive tumors involving the posterior 
surface of thc heart: cardiac autotransplantation after 
complete excision of the mass. Surgical resection of cardiac 
pheochromocytomas carries a high operative mortality 
because among the 25 patients who undcrwent surgical 
rcscction 4 dicd (16%). All four deaths were due to massivc 
blecding and occurred cither intraopcratively or shortly 
after the opcration. Moreover, nonlethal hemorrhagic com- 
plications were encountered in 4 other patients so that 8 of 
25 patients (32o/c) prescnted scrious postopcrative bleeding 
from the tumor bed. 
The two cases reportcd by Lcwis et al and Mullis et al 
illustratc perfectly thc different aspects and problems 
encountered in thc management of cardiac pheochromocy- 
tomas. Difficulties in posing the diagnosis and in localizing 
the tumor were clearly demonstrated in both cases. In Case 
1 two negative laparotomies were performed with ablation 
of two normal adrenal glands in an ltl-ycar interval before 
the cardiac tumor could be discovercd. The use of rapid- 
scquencc contrast-enhanccd CT scan and PET were of 
great help in localizing the tumor. 
The tumor sites were characteristic of cardiac pheochro- 
mocytomas because both tumors involvcd the lcft atrium 
with extension into the left ventricular structures in Case 2. 
Also illustrated in these two papers is thc difficulty in the 
surgical management. In Case 1 rescction of thc tumor 
required a largc rcsection of thc left atrium and reimplanta- 
tion of all the pulmonary veins. This is an unusual proce- 
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dure necessitating high surgical expertise. In this case, as in 
one third of the cases in the literature, postoperative 
bleeding occurred, requiring reoperation. 
In Case 2 thc massive extension of thc tumor to the lef1 
ventricle precludcd total rescction, and orthotopic heart 
transplantation was pcrformcd with SUCC~SS. This is a very 
impressive case, thc first publishcd in the world litcrature. 
Although heart transplantation may seem a high price to 
pay for cardiac pheochromocytomas, it might be a necessary 
operation when extensive involvement of thc heart or of the 
main coronary vessels is cncountered. In these cases, 
incomplete rescction rcsults in recurrcnce of symptoms, 
whereas total ablation may result in uncontrollable blecd- 
ing and/or ischemia and death. 
Diffkulty in resection is usually due either to difficult 
cxposurc when the tumor is located on the posterior aspect 
of thc heart or when involvcment of crucial structures such 
as thc main Icft coronary artery occur. Furthermore, 
cardiac pheochromocytomas are consistcntly poorly encap- 
sulated and infiltrate adjacent structures. Scveral surgical 
tcchniques have been dcscribed to help overcomc these 
difficulties including (1) transection of the aorta and pulmo- 
nary trunk offering better access to the roof of the lcft 
atrium and (2) removal of thc heart and autotransplanta- 
tion. Both of these techniques improve thc cxposurc and 
allow better manipulation in thc majority of cases; however, 
they do not constitute a radical solution when extensive 
cardiac involvcment cxists. In these rare cases orthotopic 
hcart transplantation is probably the optimal choice. The 
most difficult issue in these situations is the ability to dctect 
preopcratively the degree of cxtension of the tumor and its 
nonresectability in order to include thc patient in a prctrans- 
plant program. 
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